Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease

Journal of Infectious Diseases

Volumn 185, Issue 5, 2002, Pages 632-640

  Bakri, Faris ^a,b,d   Brauer, Aimee L ^a,b,d   Sethi, Sanjay ^a,b,d   Murphy, Timothy F ^a,b,c,d  

^a Division of Infectious Diseases   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; MORAXELLA CATARRHALIS ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; MORAXELLA CATARRHALIS; MUCOSAL IMMUNITY; PRIORITY JOURNAL; SPUTUM LEVEL; SUPERNATANT;

AGED; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN A, SECRETORY; MALE; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 0036498644     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/339174     Document Type: Article

References (29)

1. Bacterial infection in chronic obstructive pulmonary disease in 2000: A state of the art review
2. Development of bactericidal antibody during Branhamella catarrhalis infection
3. Increase in bronchopulmonary infection due to Branhamella catarrhalis
4. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease
5. Branhamella catarrhalis in respiratory secretions: Clinical correlation in 16 cases
6. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate
7. Branhamella (Neisseria) catarrhalis systemic disease in humans
8. Branhamella catarrhalis respiratory infections
9. Bronchopulmonary infection due to Branhamella catarrhalis: 11 Cases assessed by transtracheal puncture
10. Branhamella catarrhalis pneumonia
11. Bacterial infection in chronic obstructive pulmonary disease: A study of stable and exacerbated outpatients using the protected specimen brush
12. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
13. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
15. Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis
16. Isolation of the outer membrane of Branhamella catarrhalis
17. Serum antibodies to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: Identification of OMP B1 as an important antigen
18. Bacterial infection in chronic obstructive pulmonary disease
19. Branhamella catarrhalis: Epidemiology, surface antigenic structure, and immune response
20. Moraxella (Branhamella) catarrhalis: Clinical, microbiological and immunological features in lower respiratory tract infections
21. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections
22. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis
23. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis
24. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media
25. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media
26. Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection
27. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection
28. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis
29. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins